Glaucoma is the second leading cause of blindness worldwide, affecting approximately 60 million peoples 1 . The disease causes irreversible visual field (VF) damage so it is very important to predict its progression and make appropriate interventions as soon as possible. The principal target of glaucoma treatments is to reduce and control intraocular pressure (IOP), which has been shown to reduce VF progression by numerous clinical trials and research studies 2-10 . Tonometry measurements of IOP can be greatly influenced by structural properties of the eye; in particular, IOP measured with Goldmann applanation tonometry (GAT) has been shown to be affected by central corneal thickness (CCT) [11][12][13][14][15][16][17][18][19][20][21][22][23] . Thus, CCT should be considered when interpreting GAT-measured IOP and making clinical decisions. Furthermore, studies have suggested that CCT is associated with the progression of glaucoma 4,24 . Other biomechanical properties of the cornea have also been shown to affect the progression of glaucoma. In particular, corneal hysteresis (CH) and corneal resistance factor (CRF), measured with the Ocular Response Analyzer (ORA, Reichert Ophthalmic Instruments, Depew, NY, USA), have been reported to impinge on progression 25,26 .The Corneal Visualization Scheimpflug Technology instrument (Corvis ST tonometry: CST; Oculus, Wetzlar, Germany) is a new device, integrated with an ultra-high-speed Scheimpflug camera, to quantitatively measure biomechanical properties of the cornea during the application of a rapid air-puff 27 . As a result, very detailed corneal movement during the air puff application can be observed, such as velocity of corneal deformation at the first and second applanations and the maximum depth of corneal deformation (Fig. 1). Although CST and ORA both measure the biomechanical properties of the cornea, their mechanisms are completely different, and the relationship between CST-measured corneal parameters and the progression of glaucomatous VF damage